our data suggest that reduced fibrinolytic capacity due to increased plasma levels of a rapid inhibitor of t-pa may have pathogenetic importance in myocardial infarction , particularly in patients with hypertriglyceridemia .
C0032143
t-pa
C0027051
myocardial infarction